258 related articles for article (PubMed ID: 23293319)
1. Long-term results in patients with pathological complete response after induction radiochemotherapy followed by surgery for locally advanced non-small-cell lung cancer.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Mattei F; Romano R; Porziella V; Granone P
Eur J Cardiothorac Surg; 2013 Mar; 43(3):e71-81. PubMed ID: 23293319
[TBL] [Abstract][Full Text] [Related]
2. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
Meacci E; Cesario A; Cusumano G; Lococo F; D'Angelillo R; Dall'armi V; Margaritora S; Granone P
Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
[TBL] [Abstract][Full Text] [Related]
3. Is sleeve lobectomy comparable in terms of short- and long-term results with pneumonectomy after induction therapy? A multicenter analysis.
Cusumano G; Marra A; Lococo F; Margaritora S; Siciliani A; Maurizi G; Poggi C; Hillejan L; Rendina E; Granone P
Ann Thorac Surg; 2014 Sep; 98(3):975-83. PubMed ID: 25038013
[TBL] [Abstract][Full Text] [Related]
4. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
[TBL] [Abstract][Full Text] [Related]
5. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
Eberhardt WE; Gauler TC; Lepechoux C; Stamatis G; Bildat S; Krbek T; Welter S; Grunenwald D; Fischer B; Rodrigo Hde L; Theegarten D; Le Chevalier T; Seeber S; Stuschke M; Poettgen C
Lung Cancer; 2013 Oct; 82(1):83-9. PubMed ID: 23957964
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
7. Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
Perentes J; Bopp S; Krueger T; Gonzalez M; Jayet PY; Lovis A; Matzinger O; Ruffieux C; Ris HB; Letovanec I; Peters S
Ann Thorac Surg; 2012 Dec; 94(6):1815-22. PubMed ID: 23103000
[TBL] [Abstract][Full Text] [Related]
8. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
9. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
[TBL] [Abstract][Full Text] [Related]
11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
13. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
[TBL] [Abstract][Full Text] [Related]
14. Sleeve lobectomy after induction chemoradiotherapy.
Gómez-Caro A; Boada M; Reguart N; Viñolas N; Casas F; Molins L
Eur J Cardiothorac Surg; 2012 May; 41(5):1052-8. PubMed ID: 22223693
[TBL] [Abstract][Full Text] [Related]
15. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
Eberhardt W
Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686
[TBL] [Abstract][Full Text] [Related]
17. En bloc resection of non-small-cell lung cancer invading the spine.
Schirren J; Dönges T; Melzer M; Schönmayr R; Eberlein M; Bölükbas S
Eur J Cardiothorac Surg; 2011 Sep; 40(3):647-54. PubMed ID: 21334220
[TBL] [Abstract][Full Text] [Related]
18. Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
Shumway D; Corbin K; Salgia R; Hoffman P; Villaflor V; Malik RM; Haraf DJ; Vigneswaren WT; Shaikh AY; Connell PP; Ferguson MK; Salama JK
Lung Cancer; 2011 Dec; 74(3):446-50. PubMed ID: 21676484
[TBL] [Abstract][Full Text] [Related]
19. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
[TBL] [Abstract][Full Text] [Related]
20. [Impact of induction therapies on pathology and outcome after surgical resection of non-small lung cancer: a 30-year experience of 859 patients].
Mordant P; Fabre É; Gibault L; Arame A; Pricopi C; Dujon A; Le Pimpec-Barthes F; Riquet M
Rev Pneumol Clin; 2014; 70(1-2):9-15. PubMed ID: 24566030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
